The Technion’s story has been intertwined with Israel’s for more than a century, from laying the foundations for a new nation to shaping its future.
Step inside Israeli innovation at the David and Janet Polak Visitors Center. Experience our 360° immersive movie and tech exhibition. Open to individuals and groups.
Learn More
As the leading cause of death in children living in developed countries, pediatric cancer is long overdue for a safer, more targeted treatment approach – and Technion Professor Alejandro Sosnik believes he may have found one. In his lab focusing on pharmaceutical nanomaterial science in the Technion’s Faculty of Materials Science and Engineering, Prof. Sosnik […]
Cancer is the leading cause of death in Israel for both men and women, and one of the leading causes of death in the Western world. In light of this tragic fact, cancer research is considered particularly active, and in recent years it is focused on targeted therapies — treatments that aim to more effectively attack cancer cells while reducing general systemic damage, as occurs with broad-spectrum chemotherapy treatments that harm other body organs. NanoGhost, an Israeli biotech company, introduces one of the most exciting and promising technologies of recent years in this field.[OB1] NanoGhost develops a highly selective first-in-class…
“We couldn’t even begin,” Prof. Horowitz-Kraus said. “There was no school. There was chaos. And when the children finally started coming in a few weeks later, I noticed right away — something had changed.” These six-year-olds were more distracted than the children she had scanned in previous studies. They struggled to focus. Something in their […]
Israeli eye surgery robotics company ForSight Robotics has raised $125 million in a Series B round led by Eclipse. The funding will be used to advance development of the company’s ORYOM platform, a robotic system designed to perform cataract surgery and treat other common eye diseases. The system aims to deliver more precise procedures, expand access to quality care, and reduce the physical burden on surgeons. ForSight’s first human clinical trials are expected to begin this year. Founded in 2020 by Prof. Moshe Shoham, Dr. Daniel Glozman, and Dr. Joseph Nathan, ForSight is currently headquartered in Yokneam Illit and will…
“For millions living with Inflammatory Bowel Diseases (IBD), such as Crohn’s disease and ulcerative colitis (UC), every flare is a painful reminder of how little control they have over their lives. Flare-ups are unpredictable, debilitating, and costly,” said NimBio. The company has identified a clear challenge: a lack of time and actionable alerts for chronic inflammatory conditions. “But early detection changes everything: If we could spot inflammation earlier, we could reduce flare-related hospitalizations by up to 50%, saving an estimated $5 billion annually, even with conservative assumptions,” the company added. NimBio has developed a non-invasive Inflammometer™ technology that can be…
“Lung cancer and liver cancer are in the top three deadliest cancers in the world, simply because we catch it way too late,” said Ilay Marom, the co-founder and Chief Operating Officer at NaNose Medical. Founded around five and a half years ago, NaNose Medical is working to change that reality. Launched “with the purpose of revolutionizing screening tests and early diagnosis,” Marom explained in conversation with CTech, the Israeli startup is pioneering non-invasive diagnostics based on breath biomarkers. It’s technology that holds particular significance for the early detection and future treatment of liver disease and lung cancer. “Everybody knows…
On Wednesday, May 21, 2025, a delegation from the Zimin Foundation visited the Technion, led by Foundation President Boris Zimin and including Augie Fabela, co-founder and business partner of late Dr. Dmitry Zimin, and Dr. Mark Shmulevich, Director of the Zimin Institutes. During the visit, which marked a key milestone in AI-powered medical innovation at the Technion, Mr. Zimin unveiled a new plaque at the Zimin Institute for AI Solutions in Healthcare, which honors Dr. Dmitry Zimin and Mr. Boris Zimin and the inspiring legacy of the Zimin family. The delegation met with Technion President Prof. Uri Sivan, who thanked…
What does it take to achieve a slender physique? In years past, individuals seeking to lose weight needed to spend hours sweating at the gym or subject themselves to chalky meal replacement shakes. Today, there is an easier way, found through a doctor’s prescription pad. A Technion alumnus has developed a medical solution that rivals […]
Considered to be one of the greatest revolutions in cancer treatment, immunotherapy enhances the immune system’s ability to target and destroy cancer cells efficiently. One of the key challenges in immunotherapy is the uncertainty regarding patients’ responses—not all patients respond to the treatment, and some may experience side effects without meaningful therapeutic gain. Therefore, there is a need to identify biomarkers that can predict treatment effectiveness based on individual patient data. New and promising findings on this topic are now presented in a study by Technion researchers published in the journal Cell Genomics. The research was led by Prof. Keren…
The electrocardiogram (ECG) is one of the most essential tools in modern medicine, used to detect heart problems ranging from arrhythmias to structural abnormalities. In the U.S. alone, millions of ECGs are performed each year, whether in emergency rooms or routine doctor visits. As artificial intelligence (AI) systems become more advanced, they are increasingly being used to analyze ECGs—sometimes even detecting conditions that doctors might miss. The problem with this is that doctors need to understand why an AI system is making a certain diagnosis. While AI-powered ECG analysis can achieve high accuracy, it often works like a “black box,”…
About two weeks after a Russian drone struck the cover built to contain radiation at the Chernobyl nuclear power plant, Israeli biotech firm Pluri, a developer of placenta-based cell technology, landed an agreement to help Ukraine develop an emergency response to life-threatening radiation sickness in case of a radiological event. The nearly three-year war between Russia and Ukraine has underscored the ever-rising threat of nuclear fallout amid repeated shelling of a nuclear power plant in southern Ukraine and Russian President Vladimir Putin’s threat to use nuclear weapons. Last month, Haifa-based Pluri (formerly Pluristem) entered into an exclusive collaboration with Ukrainian…
A young man was brought to the emergency room of Hadassah University Medical Center in Jerusalem in traumatic cardiac arrest after shrapnel tore his inferior vena cava, the big vein in the middle of the belly. The young trauma surgeon opened the young man’s chest to start internal cardiac massage. At the same time, he instructed his team to use HemaShock, which they’d learned about when treating soldiers during army reserve duty. Applied in emergency cases of dangerously low systolic blood pressure caused by hemorrhagic shock or cardiac arrest, this unique exsanguination tourniquet squeezes all the blood from the patient’s…